These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 39406873)

  • 1. Long-Term Outcomes of Transarterial Chemoembolization of Giant Liver Hemangiomas with Lipiodol-Bleomycin Emulsion.
    Küsbeci M; Elek A; Oztürk E; Bozkaya H; Cınar C; Parıldar M; Oran I
    Cardiovasc Intervent Radiol; 2024 Nov; 47(11):1506-1514. PubMed ID: 39406873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transarterial Bleomycin-Lipiodol Embolization (B/LE) for Symptomatic Giant Hepatic Hemangioma.
    Akhlaghpoor S; Torkian P; Golzarian J
    Cardiovasc Intervent Radiol; 2018 Nov; 41(11):1674-1682. PubMed ID: 29922860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transarterial embolization with bleomycin-lipiodol emulsion: a successful minimal invasive approach for giant liver hemangioma.
    Kurniawan J; Teressa M; Budiman RA; Matondang SBRE
    Clin J Gastroenterol; 2024 Jun; 17(3):511-514. PubMed ID: 38526803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and Feasibility of Transarterial Bleomycin-Lipiodol Embolization in Patients with Giant Hepatic Hemangiomas.
    Kacała A; Dorochowicz M; Patrzałek D; Janczak D; Guziński M
    Medicina (Kaunas); 2023 Jul; 59(8):. PubMed ID: 37629648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unusual outcome following transarterial chemoembolization of giant hepatic hemangioma using bleomycin and lipiodol.
    Mikos E; Szmygin M; Kidziński R; Lesiuk P; Czeczelewski M; Pyra K
    Pol Arch Intern Med; 2024 Sep; 134(9):. PubMed ID: 39007767
    [No Abstract]   [Full Text] [Related]  

  • 6. Superselective Transarterial Chemoembolization as an Alternative to Surgery in Symptomatic/Enlarging Liver Hemangiomas.
    Özden İ; Poyanlı A; Önal Y; Demir AA; Hoş G; Acunaş B
    World J Surg; 2017 Nov; 41(11):2796-2803. PubMed ID: 28634838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcatheter Arterial Embolization with Bleomycin-Lipiodol of Hepatic Hemangiomas: Safety, Efficacy and Predictors of Response.
    Zhao D; Xie L; Makamure J; Liu Z; Zhang L; Li Q; Zhang X; Zhao Y; Zheng C; Shi L; Liang B
    Cardiovasc Intervent Radiol; 2024 Jul; 47(7):931-942. PubMed ID: 38509337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transarterial Chemoembolization of Giant Liver Haemangioma: A Multi-center Study with 836 Cases.
    Li Y; Jia Y; Li S; Wang W; Wang Z; Wang Y; Liu B; Wang W; Chang H; Li Z
    Cell Biochem Biophys; 2015 Nov; 73(2):469-472. PubMed ID: 27352340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous Sclerotherapy with Bleomycin and Ethiodized Oil: A Promising Treatment in Symptomatic Giant Liver Hemangioma.
    Ayoobi Yazdi N; Mehrabinejad MM; Dashti H; Pourghorban R; Nassiri Toosi M; Rokni Yazdi H
    Radiology; 2021 Nov; 301(2):464-471. PubMed ID: 34402664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimally invasive treatment of giant haemangiomas of the liver: embolisation with bleomycin.
    Bozkaya H; Cinar C; Besir FH; Parıldar M; Oran I
    Cardiovasc Intervent Radiol; 2014 Feb; 37(1):101-7. PubMed ID: 23580121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous Sclerotherapy for Giant Symptomatic Liver Hemangiomas: A Pilot Study.
    Ayoobi Yazdi N; Dashti H; Batavani N; Borhani A; Shakiba M; Rokni Yazdi H
    J Vasc Interv Radiol; 2018 Feb; 29(2):233-236. PubMed ID: 29414196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transarterial Bleomycin-Lipiodol Chemoembolization for the Treatment of Giant Hepatic Hemangiomas: An Assessment of Effectiveness.
    Kacała A; Dorochowicz M; Korbecki A; Sobański M; Puła M; Patrzałek D; Janczak D; Guziński M
    Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transarterial chemoembolization with cisplatin as second-line treatment for hepatocellular carcinoma unresponsive to chemoembolization with epirubicin-Lipiodol emulsion.
    Maeda N; Osuga K; Higashihara H; Tomoda K; Mikami K; Nakazawa T; Nakamura H; Tomiyama N
    Cardiovasc Intervent Radiol; 2012 Feb; 35(1):82-9. PubMed ID: 21203761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved stability of lipiodol-drug emulsion for transarterial chemoembolisation of hepatocellular carcinoma results in improved pharmacokinetic profile: Proof of concept using idarubicin.
    Boulin M; Schmitt A; Delhom E; Cercueil JP; Wendremaire M; Imbs DC; Fohlen A; Panaro F; Herrero A; Denys A; Guiu B
    Eur Radiol; 2016 Feb; 26(2):601-9. PubMed ID: 26060065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MDCT versus MRI assessment of tumor response after transarterial chemoembolization for the treatment of hepatocellular carcinoma.
    Kloeckner R; Otto G; Biesterfeld S; Oberholzer K; Dueber C; Pitton MB
    Cardiovasc Intervent Radiol; 2010 Jun; 33(3):532-40. PubMed ID: 19847482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcatheter arterial chemoembolization in patients with hepatocellular carcinoma and coexisting hepatic cavernous hemangioma.
    Chen RC; Lii JM; Chen WT; Tu HY; Chiang LC
    Eur Radiol; 2006 Jun; 16(6):1346-50. PubMed ID: 16331460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of transcatheter arterial chemoembolization with pingyangmycin-lipiodol emulsion on VX2 liver tumors in rabbits].
    Liu X; Luo XP; Cao WT; Deng H
    Zhonghua Gan Zang Bing Za Zhi; 2012 Aug; 20(8):611-6. PubMed ID: 23207156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraprocedural 3D Quantification of Lipiodol Deposition on Cone-Beam CT Predicts Tumor Response After Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma.
    Wang Z; Chen R; Duran R; Zhao Y; Yenokyan G; Chapiro J; Schernthaner R; Radaelli A; Lin M; Geschwind JF
    Cardiovasc Intervent Radiol; 2015 Dec; 38(6):1548-56. PubMed ID: 26001366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of Transarterial Embolization in Treatment of Symptomatic Hepatic Hemangiomas: Systematic Review and Meta-analysis.
    Torkian P; Li J; Kaufman JA; Jahangiri Y
    Cardiovasc Intervent Radiol; 2021 Jan; 44(1):80-91. PubMed ID: 32808203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of lipiodol infusion and drug-eluting beads transarterial chemoembolization of hepatocellular carcinoma in a real-life setting.
    Karalli A; Teiler J; Haji M; Seth E; Brismar TB; Wahlin S; Axelsson R; Stål P
    Scand J Gastroenterol; 2019 Jul; 54(7):905-912. PubMed ID: 31287338
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.